Related Experiment Video

Updated: Aug 5, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

[The clinical use of Amoxiclav in patients with suppurative meningoencephalitis]

V V Kononenko, V I Matiash, L G Vasilenko

    Likars'Ka Sprava
    |July 22, 1998
    PubMed

    Insights

    Amoxiclav demonstrates high efficacy in treating purulent meningoencephalitis, reducing symptoms and stabilizing cerebrospinal fluid. This antibiotic shows excellent sensitivity against key bacterial pathogens responsible for the disease.

    Area of Science:

    • Infectious Diseases
    • Pharmacology

    Context:

    • Purulent meningoencephalitis presents significant clinical challenges.
    • Identifying effective antimicrobial agents is crucial for patient outcomes.

    Purpose:

    • To evaluate the clinical efficacy of Amoxiclav in treating purulent meningoencephalitis.
    • To assess the in vitro sensitivity of common bacterial pathogens to Amoxiclav.

    Summary:

    • Clinical trials indicate Amoxiclav is highly effective in treating purulent meningoencephalitis, both as monotherapy and in combination with first-generation cephalosporins.
    • Treatment led to the attenuation of meningeal and encephalitic symptoms within the first week, with stabilization of liquorodynamics and cerebrospinal fluid parameters by day 8-10.
    • Bacteriological analysis revealed Amoxiclav sensitivity in up to 83.4% of prevalent bacterial flora in Ukraine, including 100% sensitivity against key pathogens like Pneumococcus, Meningococcus, and Haemophilus influenzae.

    Impact:

    • Amoxiclav offers a promising therapeutic option for purulent meningoencephalitis.
    • High in vitro sensitivity supports its use against prevalent etiological agents in the region.

    More Related Videos

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

    Published on: June 15, 2019

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Brain Abscess l: Introduction01:26

    Brain Abscess l: Introduction

    A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...